Products are supplied exclusively to qualified professionals working in compliance with all applicable laws and regulations.
Although incremental Medicare expenditures peak in the year after diagnosis and decrease in the subsequent four years, outofpocket costs have been shown to increase over time, from $3,104 in the first two years after diagnosis to $3,730 in years three to four after diagnosis, to $3,934 in years seven to eight after diagnosis (in 2017 dollars
Levines practice offers both peptide therapy and GLP-1 medications, including a microdosing option, to provide patients with potentially life-changing results
These short-lived effects are part of the cost of getting an injected therapy
Meta-analyses encompassing more than 170,000 participants have demonstrated a 25% reduction in major adverse cardiovascular events and significant reductions in all-cause mortality
TB500 is a synthetic version of thymosin beta-4, which is believed to play a role in the repair and regeneration of damaged cells and tissue